TGVSL · TGV Sraac Limited · BSE · Filed 10 Aug · 1 min read

TGV SRAAC posts higher Q1 FY27 profit, driven by chemicals

The chemicals-and-oils maker reported quarter-on-quarter and year-on-year gains in revenue and profit for the quarter ended 30 June 2026, reviewed by its statutory auditors.

What was filed

TGV SRAAC Limited filed its unaudited financial results for the first quarter ended 30 June 2026, taken on record by the Board of Directors after review by the Audit Committee on 10 August 2026. The results carry a Limited Review Report from statutory auditors Brahmayya & Co., who stated that nothing came to their attention causing them to believe the statement contains any material misstatement. A limited review is narrower in scope than a full audit and does not express an audit opinion.

The quarter in brief

Revenue from operations and profit both rose against the immediately preceding quarter (ended 31 March 2026) and against the year-ago quarter (ended 30 June 2025), per the filing. Nearly all of it sits in the Chemicals segment, which the company reports as generating the large majority of revenue and a positive segment result. The smaller Oils & Fats segment recorded a segment loss before tax and interest, and a discontinuing Power Plant operation posted a modest loss.

Why it matters to a holder

This is a routine quarterly disclosure rather than a transaction or corporate action, but it sets the current earnings run-rate and confirms the shape of the business — dominated by chemicals, with a small loss-making oils segment and a discontinuing power operation. The paid-up equity share capital was unchanged from the comparative periods, so the per-share figures reflect operating performance rather than any change in share count.

Revenue from operations (Q1 FY26): ₹49,094 → ₹51,111 → ₹54,308 lakhQ1 FY26 → Q4 FY26 → Q1 FY27+11%^‡
Profit before Tax (Q1 FY26): ₹5,235 → ₹6,217 lakhQ1 FY26 → Q1 FY27+19%^‡
Profit for the period (Q1 FY26): ₹3,875 → ₹2,799 → ₹4,542 lakhQ1 FY26 → Q4 FY26 → Q1 FY27+17%^‡
Basic EPS (continuing & discontinuing, Q1 FY26): ₹3.61 → ₹4.24Q1 FY26 → Q1 FY27+17%^‡
Net margin ‡: 7.9% → 5.5% → 8.4%Q1 FY26 → Q4 FY26 → Q1 FY27held ~8%

Chemicals segment revenue (Q1 FY27): ₹53,661 lakhs
Oils & Fats segment revenue (Q1 FY27): ₹937 lakhs
Total expenses (Q1 FY27): ₹48,441 lakhs
Paid-up equity share capital: ₹10,709 lakhs

‡ Computed by us from the filing’s own figures — not a company-stated number.

For a holder, this quarterly filing sets the current earnings baseline and confirms that the Chemicals segment remains the dominant profit driver while Oils & Fats stays a small loss-maker; it carries an auditor limited review, which offers moderate rather than full audit assurance.